-
1 Comment
Dentium CO., LTD is currently in a long term uptrend where the price is trading 19.6% above its 200 day moving average.
From a valuation standpoint, the stock is 69.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
Dentium CO., LTD's total revenue rose by 13.2% to $75B since the same quarter in the previous year.
Its net income has increased by 177.2% to $11B since the same quarter in the previous year.
Finally, its free cash flow grew by 283.5% to $39B since the same quarter in the previous year.
Based on the above factors, Dentium CO., LTD gets an overall score of 5/5.
| ISIN | KR7145720009 |
|---|---|
| Sector | Healthcare |
| Exchange | KO |
| CurrencyCode | KRW |
| Industry | Medical Instruments & Supplies |
| Market Cap | 559B |
|---|---|
| Beta | 0.9 |
| Target Price | 99000 |
| Dividend Yield | 0.8% |
| PE Ratio | None |
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 145720.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
